UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014391
Receipt number R000016066
Scientific Title Percutaneous Radiofrequency ablation for Pulmonary Metastasis from Colorectal Cancer: Phase II Clinical Trial
Date of disclosure of the study information 2014/06/27
Last modified on 2018/01/26 14:17:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Percutaneous Radiofrequency ablation for Pulmonary Metastasis from Colorectal Cancer: Phase II Clinical Trial

Acronym

SCIRO-1401 study

Scientific Title

Percutaneous Radiofrequency ablation for Pulmonary Metastasis from Colorectal Cancer: Phase II Clinical Trial

Scientific Title:Acronym

SCIRO-1401 study

Region

Japan


Condition

Condition

Pulmonary metastasis from colorectal cancer

Classification by specialty

Gastroenterology Pneumology Gastrointestinal surgery
Chest surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To prospectively evaluate the outcomes of radiofrequency ablation (RFA) for pulmonary metastases from colorectal cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

3-year overall survival

Key secondary outcomes

1- and 5-year overall survival, Adverse events, Local tumor control, Cause-specific survival, Relapse-free survival


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Lung Radiofrequency Ablation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)
(a)Colorectal cancer patients in whom primary lesion is controlled.
(b)Patients who have pulmonary metastasis diagnosed clinically and radiologically.
(c)Absence of viable extrapulmonary metastasis.
(d)All of the pulmonary metastases is considered to be treatable with RFA.
2)Pulmonary metastases with the number of less than 6 and long axis diameter of smaller than 3.0cm.
3)No disfunction of major organs.

Key exclusion criteria

1)Lack of safe needle insertion path.
2)RFA is considered to be de hazardous because of critical organs close to the target lesion.
3)Presence of sever comorbidities.
4)Presence of uncontrolled other malignant diseases.
5)Presence of peritoneal dissemination and/or malignant ascites.
6)Fever higher than 38-Celsius degree.
7)Severe impairment of contralateral pulmonary function.
8)Presence of pulmonary hypertension.
9)Presence of interstitial pneumonia.
10)Usage of anticoagulants and antiplatelet agents.
11)Pregnant patients.
12)Patients who are considered to be unsuitable for inclusion by physicians due to other reasons.

Target sample size

45


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Susumu Kanazawa

Organization

Okayama University Medical School

Division name

Department of Radiology

Zip code


Address

2-5-1 Shikatacho, Kita-ku, Okayama, Japan

TEL

086-235-7313

Email

susumu@cc.okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yusuke Matsui

Organization

Okayama University Medical School

Division name

Department of Radiology

Zip code


Address

2-5-1 Shikatacho, Kita-ku, Okayama, Japan

TEL

086-235-7313

Homepage URL


Email

wckyh140@yahoo.co.jp


Sponsor or person

Institute

Department of Radiology, Okayama University Medical School

Institute

Department

Personal name



Funding Source

Organization

Department of Radiology, Okayama University Medical School

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 06 Month 17 Day

Date of IRB


Anticipated trial start date

2014 Year 07 Month 01 Day

Last follow-up date

2018 Year 01 Month 23 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 06 Month 26 Day

Last modified on

2018 Year 01 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016066


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name